19.55 USD
+0.11 (+0.57%)
19.55 USD
0 (0%)
Taking everything into account, INVA scores 7 out of 10 in our fundamental rating. INVA was compared to 191 industry peers in the Pharmaceuticals industry. INVA has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. A decent growth rate in combination with a cheap valuation! Better keep an eye on INVA. These ratings would make INVA suitable for value and quality investing!
1. Profitability
1.1 Basic Checks
- INVA had positive earnings in the past year.
- In the past year INVA had a positive cash flow from operations.
- Each year in the past 5 years INVA has been profitable.
- In the past 5 years INVA always reported a positive cash flow from operatings.
1.2 Ratios
- INVA's Return On Assets of 8.91% is amongst the best of the industry. INVA outperforms 90.58% of its industry peers.
- With an excellent Return On Equity value of 12.61%, INVA belongs to the best of the industry, outperforming 86.91% of the companies in the same industry.
- With an excellent Return On Invested Capital value of 9.43%, INVA belongs to the best of the industry, outperforming 88.48% of the companies in the same industry.
- INVA had an Average Return On Invested Capital over the past 3 years of 11.38%. This is in line with the industry average of 12.84%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.91% | ||
| ROE | 12.61% | ||
| ROIC | 9.43% |
ROA(3y)11.21%
ROA(5y)16.95%
ROE(3y)22.61%
ROE(5y)34.7%
ROIC(3y)11.38%
ROIC(5y)18.16%
1.3 Margins
- Looking at the Profit Margin, with a value of 32.78%, INVA belongs to the top of the industry, outperforming 95.81% of the companies in the same industry.
- In the last couple of years the Profit Margin of INVA has declined.
- INVA has a Operating Margin of 43.21%. This is amongst the best in the industry. INVA outperforms 97.91% of its industry peers.
- In the last couple of years the Operating Margin of INVA has declined.
- With an excellent Gross Margin value of 81.50%, INVA belongs to the best of the industry, outperforming 84.82% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 43.21% | ||
| PM (TTM) | 32.78% | ||
| GM | 81.5% |
OM growth 3Y-21.38%
OM growth 5Y-13.2%
PM growth 3Y-54.19%
PM growth 5Y-35.9%
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), INVA is creating some value.
- The number of shares outstanding for INVA has been reduced compared to 1 year ago.
- Compared to 5 years ago, INVA has less shares outstanding
- The debt/assets ratio for INVA has been reduced compared to a year ago.
2.2 Solvency
- An Altman-Z score of 3.39 indicates that INVA is not in any danger for bankruptcy at the moment.
- INVA's Altman-Z score of 3.39 is fine compared to the rest of the industry. INVA outperforms 65.97% of its industry peers.
- INVA has a debt to FCF ratio of 1.38. This is a very positive value and a sign of high solvency as it would only need 1.38 years to pay back of all of its debts.
- INVA's Debt to FCF ratio of 1.38 is amongst the best of the industry. INVA outperforms 95.81% of its industry peers.
- INVA has a Debt/Equity ratio of 0.25. This is a healthy value indicating a solid balance between debt and equity.
- With a Debt to Equity ratio value of 0.25, INVA perfoms like the industry average, outperforming 42.93% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.25 | ||
| Debt/FCF | 1.38 | ||
| Altman-Z | 3.39 |
ROIC/WACC1.11
WACC8.53%
2.3 Liquidity
- A Current Ratio of 14.12 indicates that INVA has no problem at all paying its short term obligations.
- With an excellent Current ratio value of 14.12, INVA belongs to the best of the industry, outperforming 83.77% of the companies in the same industry.
- INVA has a Quick Ratio of 13.33. This indicates that INVA is financially healthy and has no problem in meeting its short term obligations.
- The Quick ratio of INVA (13.33) is better than 82.72% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 14.12 | ||
| Quick Ratio | 13.33 |
3. Growth
3.1 Past
- INVA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 98.55%, which is quite impressive.
- INVA shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -33.21% yearly.
- Looking at the last year, INVA shows a quite strong growth in Revenue. The Revenue has grown by 10.14% in the last year.
- INVA shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.57% yearly.
EPS 1Y (TTM)98.55%
EPS 3Y-52.04%
EPS 5Y-33.21%
EPS Q2Q%5300%
Revenue 1Y (TTM)10.14%
Revenue growth 3Y-2.91%
Revenue growth 5Y6.57%
Sales Q2Q%20.44%
3.2 Future
- Based on estimates for the next years, INVA will show a very strong growth in Earnings Per Share. The EPS will grow by 78.97% on average per year.
- The Revenue is expected to grow by 9.78% on average over the next years. This is quite good.
EPS Next Y1027.37%
EPS Next 2Y239.14%
EPS Next 3Y129.33%
EPS Next 5Y78.97%
Revenue Next Year12.59%
Revenue Next 2Y10.56%
Revenue Next 3Y9.71%
Revenue Next 5Y9.78%
3.3 Evolution
- The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
- The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- With a Price/Earnings ratio of 14.27, INVA is valued correctly.
- INVA's Price/Earnings ratio is rather cheap when compared to the industry. INVA is cheaper than 86.91% of the companies in the same industry.
- Compared to an average S&P500 Price/Earnings ratio of 26.94, INVA is valued a bit cheaper.
- Based on the Price/Forward Earnings ratio of 8.95, the valuation of INVA can be described as reasonable.
- Based on the Price/Forward Earnings ratio, INVA is valued cheaper than 89.01% of the companies in the same industry.
- When comparing the Price/Forward Earnings ratio of INVA to the average of the S&P500 Index (23.94), we can say INVA is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.27 | ||
| Fwd PE | 8.95 |
4.2 Price Multiples
- 97.91% of the companies in the same industry are more expensive than INVA, based on the Enterprise Value to EBITDA ratio.
- Compared to the rest of the industry, the Price/Free Cash Flow ratio of INVA indicates a rather cheap valuation: INVA is cheaper than 93.72% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 7.81 | ||
| EV/EBITDA | 5.43 |
4.3 Compensation for Growth
- INVA's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
- INVA has a very decent profitability rating, which may justify a higher PE ratio.
- INVA's earnings are expected to grow with 129.33% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.01
PEG (5Y)N/A
EPS Next 2Y239.14%
EPS Next 3Y129.33%
5. Dividend
5.1 Amount
- INVA does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
19.55
+0.11 (+0.57%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)11-05 2025-11-05/amc
Earnings (Next)02-24 2026-02-24/amc
Inst Owners106.59%
Inst Owner Change0.13%
Ins Owners1.07%
Ins Owner Change3.56%
Market Cap1.46B
Revenue(TTM)388.52M
Net Income(TTM)127.34M
Analysts80
Price Target33.15 (69.57%)
Short Float %8.11%
Short Ratio6.71
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)85.21%
Min EPS beat(2)50.98%
Max EPS beat(2)119.45%
EPS beat(4)2
Avg EPS beat(4)-52.71%
Min EPS beat(4)-350.17%
Max EPS beat(4)119.45%
EPS beat(8)4
Avg EPS beat(8)-30.46%
EPS beat(12)6
Avg EPS beat(12)-44.02%
EPS beat(16)7
Avg EPS beat(16)-43.24%
Revenue beat(2)2
Avg Revenue beat(2)11.28%
Min Revenue beat(2)6.82%
Max Revenue beat(2)15.75%
Revenue beat(4)4
Avg Revenue beat(4)7.84%
Min Revenue beat(4)3.7%
Max Revenue beat(4)15.75%
Revenue beat(8)8
Avg Revenue beat(8)12.47%
Revenue beat(12)11
Avg Revenue beat(12)11.27%
Revenue beat(16)11
Avg Revenue beat(16)-2.38%
PT rev (1m)0.78%
PT rev (3m)-20.73%
EPS NQ rev (1m)0%
EPS NQ rev (3m)36.36%
EPS NY rev (1m)0%
EPS NY rev (3m)80%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)2.03%
Revenue NY rev (1m)0%
Revenue NY rev (3m)4.87%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.27 | ||
| Fwd PE | 8.95 | ||
| P/S | 3.76 | ||
| P/FCF | 7.81 | ||
| P/OCF | 7.25 | ||
| P/B | 1.45 | ||
| P/tB | 1.97 | ||
| EV/EBITDA | 5.43 |
EPS(TTM)1.37
EY7.01%
EPS(NY)2.19
Fwd EY11.18%
FCF(TTM)2.5
FCFY12.8%
OCF(TTM)2.7
OCFY13.8%
SpS5.2
BVpS13.51
TBVpS9.95
PEG (NY)0.01
PEG (5Y)N/A
Graham Number20.41
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.91% | ||
| ROE | 12.61% | ||
| ROCE | 12.16% | ||
| ROIC | 9.43% | ||
| ROICexc | 15.37% | ||
| ROICexgc | 22.41% | ||
| OM | 43.21% | ||
| PM (TTM) | 32.78% | ||
| GM | 81.5% | ||
| FCFM | 48.17% |
ROA(3y)11.21%
ROA(5y)16.95%
ROE(3y)22.61%
ROE(5y)34.7%
ROIC(3y)11.38%
ROIC(5y)18.16%
ROICexc(3y)16.17%
ROICexc(5y)24.46%
ROICexgc(3y)28.95%
ROICexgc(5y)34.96%
ROCE(3y)14.67%
ROCE(5y)23.41%
ROICexgc growth 3Y-8.78%
ROICexgc growth 5Y-15.28%
ROICexc growth 3Y-21.15%
ROICexc growth 5Y-17.48%
OM growth 3Y-21.38%
OM growth 5Y-13.2%
PM growth 3Y-54.19%
PM growth 5Y-35.9%
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.27
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.25 | ||
| Debt/FCF | 1.38 | ||
| Debt/EBITDA | 1.24 | ||
| Cap/Depr | 36.13% | ||
| Cap/Sales | 3.73% | ||
| Interest Coverage | 16.22 | ||
| Cash Conversion | 96.95% | ||
| Profit Quality | 146.98% | ||
| Current Ratio | 14.12 | ||
| Quick Ratio | 13.33 | ||
| Altman-Z | 3.39 |
F-Score6
WACC8.53%
ROIC/WACC1.11
Cap/Depr(3y)4.13%
Cap/Depr(5y)2.48%
Cap/Sales(3y)0.45%
Cap/Sales(5y)0.27%
Profit Quality(3y)320.3%
Profit Quality(5y)247.45%
High Growth Momentum
Growth
EPS 1Y (TTM)98.55%
EPS 3Y-52.04%
EPS 5Y-33.21%
EPS Q2Q%5300%
EPS Next Y1027.37%
EPS Next 2Y239.14%
EPS Next 3Y129.33%
EPS Next 5Y78.97%
Revenue 1Y (TTM)10.14%
Revenue growth 3Y-2.91%
Revenue growth 5Y6.57%
Sales Q2Q%20.44%
Revenue Next Year12.59%
Revenue Next 2Y10.56%
Revenue Next 3Y9.71%
Revenue Next 5Y9.78%
EBIT growth 1Y4.12%
EBIT growth 3Y-23.66%
EBIT growth 5Y-7.5%
EBIT Next Year38.24%
EBIT Next 3Y15.74%
EBIT Next 5YN/A
FCF growth 1Y60.93%
FCF growth 3Y-20.27%
FCF growth 5Y-6.46%
OCF growth 1Y72.8%
OCF growth 3Y-19.65%
OCF growth 5Y-6.03%
INNOVIVA INC / INVA FAQ
Can you provide the ChartMill fundamental rating for INNOVIVA INC?
ChartMill assigns a fundamental rating of 7 / 10 to INVA.
Can you provide the valuation status for INNOVIVA INC?
ChartMill assigns a valuation rating of 9 / 10 to INNOVIVA INC (INVA). This can be considered as Undervalued.
What is the profitability of INVA stock?
INNOVIVA INC (INVA) has a profitability rating of 7 / 10.
What is the earnings growth outlook for INNOVIVA INC?
The Earnings per Share (EPS) of INNOVIVA INC (INVA) is expected to grow by 1027.37% in the next year.
How sustainable is the dividend of INNOVIVA INC (INVA) stock?
The dividend rating of INNOVIVA INC (INVA) is 0 / 10 and the dividend payout ratio is 0%.